Thomas Kline, PhD
Biochemist · Medical Reviewer
Thomas Kline, PhD is a biochemist with a doctorate in structural biochemistry from MIT and 16 years of research in peptide and protein therapeutics. His work has focused on GLP receptor biology, incretin hormone pharmacology, and the structure-activity relationships of synthetic peptide analogs targeting GLP-1, GIP, and glucagon receptors.
He has contributed to peer-reviewed publications in structural pharmacology and incretin-based compound development. His expertise in receptor selectivity, peptide binding kinetics, and the biochemical basis of triple-agonist activity gives him direct authority over the scientific content covered by Peptide Reta.
As medical reviewer for Peptide Reta, Dr. Kline evaluates the site's educational content for accuracy in describing peptide molecular structure, receptor selectivity mechanisms, and the biochemical properties of retatrutide and related GLP receptor agonists.
Training & Credentials
- PhD, Structural Biochemistry — Massachusetts Institute of Technology (MIT)
- Postdoctoral Research — Salk Institute for Biological Studies
- BS, Molecular Biology — University of Wisconsin–Madison
Areas of Expertise
Dr. Kline reviews Peptide Reta content for accuracy in describing peptide molecular structure, receptor selectivity mechanisms, and the biochemical properties of retatrutide and other GLP receptor agonist compounds.